Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
60.6M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
12.1M
-
Shares change
-
+12.1M
-
Total reported value, excl. options
-
$316M
-
Value change
-
+$316M
-
Number of buys
-
38
-
Price
-
$26.55
Significant Holders of Immuneering Corp - Class A Common Stock (IMRX) as of Q3 2021
38 filings reported holding IMRX - Immuneering Corp - Class A Common Stock as of Q3 2021.
Immuneering Corp - Class A Common Stock (IMRX) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.1M shares
of 60.6M outstanding shares and own 19.98% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (3.11M shares), Cormorant Asset Management, LP (2.25M shares), CITADEL ADVISORS LLC (2.06M shares), BlackRock Inc. (1.52M shares), Rock Springs Capital Management LP (1.09M shares), PERCEPTIVE ADVISORS LLC (681K shares), VANGUARD GROUP INC (344K shares), FMR LLC (250K shares), SUVRETTA CAPITAL MANAGEMENT, LLC (200K shares), and GEODE CAPITAL MANAGEMENT, LLC (122K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.